These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34563948)

  • 1. The role and mechanism of HLA complex group 11 in cancer.
    Yuan X; Zhao Q; Zhang Y; Xue M
    Biomed Pharmacother; 2021 Nov; 143():112210. PubMed ID: 34563948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA HCG11 inhibited growth and invasion in cervical cancer by sponging miR-942-5p and targeting GFI1.
    Zhang Y; Zhang J; Mao L; Li X
    Cancer Med; 2020 Oct; 9(19):7062-7071. PubMed ID: 32794340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA HCG11/miR-579-3p/MDM2 axis modulates malignant biological properties in pancreatic carcinoma via Notch/Hes1 signaling pathway.
    Xu J; Xu W; Yang X; Liu Z; Sun Q
    Aging (Albany NY); 2021 Jun; 13(12):16471-16484. PubMed ID: 34230221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA HCG11 modulates glioma progression through cooperating with miR-496/CPEB3 axis.
    Chen Y; Bao C; Zhang X; Lin X; Huang H; Wang Z
    Cell Prolif; 2019 Sep; 52(5):e12615. PubMed ID: 31310044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA HCG11 suppresses the growth of glioma by cooperating with the miR-4425/MTA3 axis.
    Zhang L; Cao Y; Kou X; Che L; Zhou X; Chen G; Zhao J
    J Gene Med; 2019 Apr; 21(4):e3074. PubMed ID: 30706982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dual functions of the long noncoding RNA CASC15 in malignancy.
    Gu X; Chu Q; Zheng Q; Wang J; Zhu H
    Biomed Pharmacother; 2021 Mar; 135():111212. PubMed ID: 33433353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of lncRNA HCG11 promotes cell proliferation of oral squamous cell carcinoma through sponging miR-455-5p.
    Wu J; Li Y; Liu J; Xu Y
    J Gene Med; 2021 Mar; 23(3):e3293. PubMed ID: 33151000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA HCG11 accelerates the progression of hepatocellular carcinoma via miR-26a-5p/ATG12 axis.
    Li ML; Zhang Y; Ma LT
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10708-10720. PubMed ID: 31858580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lncRNA HCG11 suppresses cell proliferation in hormone receptor-positive breast cancer via SRSF1/β-catenin.
    Xie D; Li S; Wang X; Fang L
    Aging (Albany NY); 2023 Jan; 15(1):179-192. PubMed ID: 36602530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA HCG11 suppresses human osteosarcoma growth through upregulating p27 Kip1.
    Gu J; Dai B; Shi X; He Z; Xu Y; Meng X; Zhu J
    Aging (Albany NY); 2021 Sep; 13(17):21743-21757. PubMed ID: 34518440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional mechanism and clinical implications of MicroRNA-423 in human cancers.
    Ke R; Lv L; Zhang S; Zhang F; Jiang Y
    Cancer Med; 2020 Dec; 9(23):9036-9051. PubMed ID: 33174687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA HCG11 suppresses laryngeal carcinoma cells progression via sponging miR-4469/APOM axis.
    Xue HX; Li HF; Wang T; Li WJ; Bian WC
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3174-3182. PubMed ID: 32271435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TUG1: a pivotal oncogenic long non-coding RNA of human cancers.
    Li Z; Shen J; Chan MT; Wu WK
    Cell Prolif; 2016 Aug; 49(4):471-5. PubMed ID: 27339553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA HCG11 Inhibits Adipocyte Differentiation in Human Adipose-Derived Mesenchymal Stem Cells by Sponging miR-204-5p to Upregulate SIRT1.
    Li D; Liu Y; Gao W; Han J; Yuan R; Zhang M; Ge Z
    Cell Transplant; 2020; 29():963689720968090. PubMed ID: 33086891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of long non-coding RNA HCG11 predicts a poor prognosis in prostate cancer.
    Zhang Y; Zhang P; Wan X; Su X; Kong Z; Zhai Q; Xiang X; Li L; Li Y
    Biomed Pharmacother; 2016 Oct; 83():936-941. PubMed ID: 27522256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deleted in lymphocytic leukemia 2 (DLEU2): An lncRNA with dissimilar roles in different cancers.
    Ghafouri-Fard S; Dashti S; Farsi M; Taheri M
    Biomed Pharmacother; 2021 Jan; 133():111093. PubMed ID: 33378985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer.
    Malek E; Jagannathan S; Driscoll JJ
    Oncotarget; 2014 Sep; 5(18):8027-38. PubMed ID: 25275300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of lncRNA LUCAT1 in cancer.
    Xing C; Sun SG; Yue ZQ; Bai F
    Biomed Pharmacother; 2021 Feb; 134():111158. PubMed ID: 33360049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Application of lncRNAs in Cancer Treatment and Diagnosis.
    Zhang Y; Tang L
    Recent Pat Anticancer Drug Discov; 2018; 13(3):292-301. PubMed ID: 29485010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCYRN1: An oncogenic lncRNA in diverse cancers.
    Ghafouri-Fard S; Dashti S; Hussen BM; Farsi M; Taheri M
    Pathol Res Pract; 2021 Apr; 220():153385. PubMed ID: 33647864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.